173 related articles for article (PubMed ID: 36685546)
61. T cell activation by a bispecific anti-CD3/anti-major histocompatibility complex class I antibody.
Roosnek E; Tunnacliffe A; Lanzavecchia A
Eur J Immunol; 1990 Jun; 20(6):1393-6. PubMed ID: 2142461
[TBL] [Abstract][Full Text] [Related]
62. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
[TBL] [Abstract][Full Text] [Related]
63. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
[TBL] [Abstract][Full Text] [Related]
64. Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers.
Walseng E; Wang B; Yang C; Patel P; Zhao C; Zhang H; Zhao P; Mazor Y
Front Immunol; 2023; 14():1275304. PubMed ID: 38022650
[TBL] [Abstract][Full Text] [Related]
65. The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor zeta subunits and the CD3 gamma, delta and epsilon chains.
Osman N; Turner H; Lucas S; Reif K; Cantrell DA
Eur J Immunol; 1996 May; 26(5):1063-8. PubMed ID: 8647168
[TBL] [Abstract][Full Text] [Related]
66. Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells.
Hall C; Berkhout B; Alarcon B; Sancho J; Wileman T; Terhorst C
Int Immunol; 1991 Apr; 3(4):359-68. PubMed ID: 1831654
[TBL] [Abstract][Full Text] [Related]
67. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production.
Waclavicek M; Majdic O; Stulnig T; Berger M; Sunder-Plassmann R; Zlabinger GJ; Baumruker T; Stöckl J; Ebner C; Knapp W; Pickl WF
J Immunol; 1998 Nov; 161(9):4671-8. PubMed ID: 9794396
[TBL] [Abstract][Full Text] [Related]
68. Antigen-induced TCR-CD3 down-modulation does not require CD3delta or CD3gamma cytoplasmic domains, necessary in response to anti-CD3 antibody.
Legendre V; Guimezanes A; Buferne M; Barad M; Schmitt-Verhulst AM; Boyer C
Int Immunol; 1999 Nov; 11(11):1731-8. PubMed ID: 10545476
[TBL] [Abstract][Full Text] [Related]
69. A simplified function-first method for the discovery and optimization of bispecific immune engaging antibodies.
Shepherd A; Bennychen B; Marcil A; Bloemberg D; Pon RA; Weeratna RD; McComb S
PLoS One; 2023; 18(6):e0273884. PubMed ID: 37347762
[TBL] [Abstract][Full Text] [Related]
70. Molecular and cellular analysis of human T lymphocytes expressing gamma delta T-cell receptor.
Moretta L; Ciccone E; Ferrini S; Pelicci PG; Mingari MC; Zeromski J; Bottino C; Grossi C; Moretta A
Immunol Rev; 1991 Apr; 120():117-35. PubMed ID: 1650757
[TBL] [Abstract][Full Text] [Related]
71. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
[TBL] [Abstract][Full Text] [Related]
72. Phenotype, activation and lymphokine secretion by gamma/delta T lymphocytes from schistosomiasis and carcinoma of the urinary bladder.
Raziuddin S; Shetty S; Ibrahim A
Eur J Immunol; 1992 Feb; 22(2):309-14. PubMed ID: 1531634
[TBL] [Abstract][Full Text] [Related]
73. MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Hernandez-Hoyos G; Sewell T; Bader R; Bannink J; Chenault RA; Daugherty M; Dasovich M; Fang H; Gottschalk R; Kumer J; Miller RE; Ravikumar P; Wiens J; Algate PA; Bienvenue D; McMahan CJ; Natarajan SK; Gross JA; Blankenship JW
Mol Cancer Ther; 2016 Sep; 15(9):2155-65. PubMed ID: 27406985
[TBL] [Abstract][Full Text] [Related]
74. Different cytoplasmic structure of the CD3 zeta family dimer modulates the activation signal and function of T cells.
Aoe T; Goto S; Ohno H; Saito T
Int Immunol; 1994 Nov; 6(11):1671-9. PubMed ID: 7865460
[TBL] [Abstract][Full Text] [Related]
75. The gamma T-cell antigen receptor.
Lanier LL; Serafini AT; Ruitenberg JJ; Cwirla S; Federspiel NA; Phillips JH; Allison JP; Weiss A
J Clin Immunol; 1987 Nov; 7(6):429-40. PubMed ID: 3320076
[TBL] [Abstract][Full Text] [Related]
76. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Rosato F; Pasupuleti R; Tomisch J; Meléndez AV; Kolanovic D; Makshakova ON; Wiltschi B; Römer W
J Transl Med; 2022 Dec; 20(1):578. PubMed ID: 36494671
[TBL] [Abstract][Full Text] [Related]
77. Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8.
Michalk I; Feldmann A; Koristka S; Arndt C; Cartellieri M; Ehninger A; Ehninger G; Bachmann MP
PLoS One; 2014; 9(4):e95517. PubMed ID: 24751697
[TBL] [Abstract][Full Text] [Related]
78. Role of CD3 delta in surface expression of the TCR/CD3 complex and in activation for killing analyzed with a CD3 delta-negative cytotoxic T lymphocyte variant.
Buferne M; Luton F; Letourneur F; Hoeveler A; Couez D; Barad M; Malissen B; Schmitt-Verhulst AM; Boyer C
J Immunol; 1992 Feb; 148(3):657-64. PubMed ID: 1530953
[TBL] [Abstract][Full Text] [Related]
79. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes.
Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L
Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830
[TBL] [Abstract][Full Text] [Related]
80. Cytokine synthesis and apoptosis by intestinal intraepithelial lymphocytes: signaling of high density alpha beta T cell receptor+ and gamma delta T cell receptor+ T cells via T cell receptor-CD3 complex results in interferon-gamma and interleukin-5 production, while low density T cells undergo DNA fragmentation.
Yamamoto M; Fujihashi K; Amano M; McGhee JR; Beagley KW; Kiyono H
Eur J Immunol; 1994 Jun; 24(6):1301-6. PubMed ID: 8206090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
